KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8(+) T-cell-dependent antitumor immunity

Background: Immune checkpoint blockers (ICBs) are revolutionized therapeutic strategies for cancer, but most patients with solid neoplasms remain resistant to ICBs, partly because of the difficulty in reversing the highly immunosuppressive tumor microenvironment (TME). Exploring the strategies for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qi, Liu, Zhou, Gao, Zhijie, Luo, Yao, Li, Fubing, Yang, ChuanYu, Wang, Tiantian, Meng, Xiangyu, Chen, Haijun, Li, Juanjuan, Kong, Yanjie, Dong, Chao, Sun, Si, Chen, Ceshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008740/
https://www.ncbi.nlm.nih.gov/pubmed/36923542
http://dx.doi.org/10.7150/thno.82182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008740/
https://www.ncbi.nlm.nih.gov/pubmed/36923542
http://dx.doi.org/10.7150/thno.82182

Ejemplares similares